Dopamine Beta Hydroxylase Deficiency
Also known as: Dopamine Beta-Hydroxylase Deficiency / Dopamine beta-hydroxylase deficiency (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06262 | Droxidopa | A medication used to treat symptomatic neurogenic orthostatic hypotension (nOH) caused by dopamine beta-hydroxylase deficiency, non-diabetic autonomic neuropathy and primary autonomic failure caused by conditions such as Parkinson's disease. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00572 | Atropine | 1 | Completed | 1 |
DB11105 | Benzalkonium | 1 | Completed | 1 |
DB00575 | Clonidine | 1 | Completed | 1 |
DB01010 | Edrophonium | 1 | Completed | 1 |
DB01064 | Isoprenaline | 1 | Completed | 1 |
DB00968 | Methyldopa | 1 | Completed | 1 |
DB01233 | Metoclopramide | 1 | Completed | 1 |
DB00325 | Nitroprusside | 1 | Completed | 1 |
DB00388 | Phenylephrine | 1 | Completed | 1 |
DB00571 | Propranolol | 1 | Completed | 1 |
DB08841 | Tyramine | 1 | Completed | 1 |
DB01392 | Yohimbine | 1 | Completed | 1 |
DB06262 | Droxidopa | 2 / 3 | Terminated | 1 |
DB06262 | Droxidopa | 3 | Completed | 4 |
DB06262 | Droxidopa | 3 | Terminated | 1 |
DB00742 | Mannitol | 3 | Terminated | 1 |